Literature DB >> 1206754

Prognosis in Kaposi's sarcoma.

A C Templeton, D Bhana.   

Abstract

We studied and followed up 112 African patients with Kaposi's sarcoma for at least 3 years or until death to determine what features of the disease at presentation most accurately predicted the prognosis. The clinical pattern of disease at presentation was most important. All patients with generalized disease died of their disease; the only deaths among those with nodular disease were due to intercurrent illness. The 3-year survuval rate among patients with locally aggressive lesions with 64%. We could obtain greater refinement of prognosis by noting the response to a dinitrochlorobenzene challenge, the presence of nodal involvement, and the histologic pattern of the tumor. The age and sex of the patient influenced the pattern of disease likely to be found, but the prognosis for a given clinical pattern was the same in both sexes and at different ages.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1206754     DOI: 10.1093/jnci/55.6.1301

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  The acquired immune deficiency syndrome (AIDS)--a multidisciplinary enigma.

Authors: 
Journal:  West J Med       Date:  1984-01

2.  Survival of classic Kaposi's sarcoma and risk of second cancer.

Authors:  S Franceschi; S Arniani; D Balzi; M Geddes
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

3.  Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma.

Authors:  Érico Arruda; Alexandre Andrade dos Anjos Jacome; Ana Luiza de Castro Conde Toscano; Anderson Arantes Silvestrini; André Santa Bárbara Rêgo; Evanius Garcia Wiermann; Geraldo Felicio da Cunha; Heloisa Ramos Lacerda de Melo; Karen Mirna Loro Morejón; Luciano Zubaran Goldani; Luiz Carlos Pereira; Mariliza Henrique Silva; Mauro Sergio Treistman; Mônica Cristina Toledo Pereira; Patricia Maria Bezerra Xavier Romero; Rafael Aron Schmerling; Rodrigo Antonio Vieira Guedes; Veridiana Pires de Camargo
Journal:  Braz J Infect Dis       Date:  2014-02-11       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.